Evaluation of the incidence of bleeding in patients prescribed rivaroxaban for the treatment and prevention of deep vein thrombosis and pulmonary embolism in UK secondary care: an observational cohort study

OBJECTIVES: To evaluate the short-term (12 weeks) safety and utilisation of rivaroxaban prescribed to new-user adult patients for the treatment of deep vein thrombosis and pulmonary embolism and for the prevention of recurrent deep vein thrombosis and pulmonary embolism in a secondary care setting i...

Descripción completa

Detalles Bibliográficos
Autores principales: Evans, Alison, Davies, Miranda, Osborne, Vicki, Roy, Debabrata, Shakir, Saad
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2020
Materias:
Cardiovascular Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7640735/
https://www.ncbi.nlm.nih.gov/pubmed/33148732
http://dx.doi.org/10.1136/bmjopen-2020-038102

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7640735/
https://www.ncbi.nlm.nih.gov/pubmed/33148732
http://dx.doi.org/10.1136/bmjopen-2020-038102

Ejemplares similares